Pharmacogenomics

HER2 Is Not a Cancer Subtype but Rather a PanCancer Event - Research in breast cancer genomics reveals the potential for combining antiHER2 therapy with antiandrogen agents. Breast Cancer Research ow.ly/feqz50gXnpF

Market Share Costs of Biologic Therapies for IBD in the USA - This study examined trends in the use of biologics for IBD relative market share compared to other medication classes and costs in the USA during a 9year period. Alimentary Pharmacology & T... ow.ly/tfEo50gXnpG

Proteostasis Therapeutics Inc PTI Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300 - SummaryProteostasis Therapeutics Inc PTI formerly Proteoguard Inc a subsidiary of Perrigo Company Plc is a developer of groun... ow.ly/4R5T50gXjP9

Comment Population monitoring for drugresistant tuberculosis is genomics the answer - The first approximation akin to a population survey of drug resistance in tuberculosis was done in the UK in the 1950s just a few years after the introduction of str... ow.ly/kqnb50gXjP8

New ID NIMBUSÂ from Hamilton Robotics Automates Verogens ForenSeq DNA Signature Prep Kit in Forensic Genomics Applications - Automated nextgeneration sequencing NGS solution increases efficiency and reduces manual intervention for up to 96 samples per... ow.ly/k8qT50gXfTB

Eurofins MWG Operon LLC Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09032018 Prices from USD $250 - SummaryEurofins MWG Operon LLC Eurofins is a biotechnology company that provides DNA sequencing DNA synthesis and bioinformat... ow.ly/WYca50gXe6n

Ctcbio Inc 060590 Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300 - SummaryCtcbio Inc CTCBIO is a manufacturer and marketer of pharmaceuticals veterinary drugs animal feed supplements and functional food produ... ow.ly/bBD850gX8f8

Comment on Clinical significance of BRAF nonV600E mutations on the therapeutic effects of antiEGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer the Biomarker Research for antiEGFR monoclonal Antibodi ow.ly/kDBu50gWWTP

Reply to Comment on Clinical significance of BRAF nonV600E mutations on the therapeutic effects of antiEGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer the Biomarker Research for antiEGFR monoclonal Antibod ow.ly/DV4M50gWWTQ

Rosetta Genomics Ltd ROSG Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300 - SummaryRosetta Genomics Ltd RGL is a developer of next generation diagnostic tests for personalized medicine. The company provides te... ow.ly/IfJg50gWL9E

Society for Reproductive Investigation SRI Receives ThreeYear Award from the Eunice Kennedy Shriver National Institute of Child Health & Human Development NICHD - The R13 Grant Program through NICHD will support the SRI Annual Scientific Meeting in 20... ow.ly/G7lH50gWEHS

NSAID use linked to increased risk of atrial fibrillation - Use of nonsteroidal antiinflammatory drugs NSAIDs was associated with an 18 increased risk of atrial fibrillationan irregular often rapid heart ratein a study of middleaged adults in Taiwan. ... ow.ly/6PYM50gWEHT

Horizon Discoverys Bioproduction cell line used as part of a successful drug IND filing - Horizon’s Glutamine SynthetaseKnockout CHO K1 cell line has been used as part of a successful Investigational New Drug filing with the FDA Filing further v... ow.ly/qdTa50gWlzp

EUROPE DNA SEQUENCING MARKET FORECAST 20182026 Report Updated 15012018 Prices from USD $1250 - KEY FINDINGSIn 2017 the Europe DNA sequencing market captured a share of $2224 million in the global market. By the end of the forecast period of 20182026 t... ow.ly/49Qd50gWgCe

Ex Scientia Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09032018 Prices from USD $250 - SummaryEx Scientia Ltd Ex Scientia is a biotechnology company that develops compounds with tailored polypharmacology. The company dev... ow.ly/14O750gVKNs

Inova Health System Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 15022018 Prices from USD $250 - SummaryInova Health System Inova is a nonprofit health care system operating through multiple hospitals. It offers home health an... ow.ly/JCbq50gVCPV

Quanterix Corporation and DestiNA Genomics to Collaborate in Effort to Transform microRNA Biomarker Detection - Collaboration offers potential for PCRfree microRNA biomarker detection with highspecificity and ultrasensitivity Quanterix Corporation NAS... ow.ly/C9dN50gVy16

Switching From Infliximab to Biosimilar in Patients With IBD - Two infliximab biosimilars are currently available for the treatment of inflammatory bowel disease at a much lower cost than infliximab innovator. Can patients be safely switched Alimentar... ow.ly/RVqt50gVunP

Kalytera Initiates Program to Develop a Novel CannabinoidBased Compound for Treatment of Acute and Chronic Pain - Kalytera Therapeutics Inc. TSX VENTURE KALY and OTCQB KALTF the "Company" or "Kalytera" today announced that it has begun development of ... ow.ly/9mlZ50gVunR

SYGNIS AG SYGNIS AG raise approximately EUR 4.2 million in private placement - SYGNIS AG Key words Capital IncreaseSYGNIS AG SYGNIS AG raise approximately EUR 4.2 million in private placement 20March2018 1144 CETCESTDisclosure of an inside information... ow.ly/6aoZ50gVunQ